Senju Pharm. Co. v. Lupin Ltd.
Addressing the issue of obviousness, the U.S. Court of Appeals
for the Federal Circuit adopted a deferential review stance toward
the district court's characterization of several prior art
references and ultimately upheld its judgment that the asserted
claims were obvious. Senju Pharm. Co. v. Lupin Ltd.,
Case No. 13-1630 (Fed. Cir., Mar. 20, 2015) (Plager, J.) (Newman,
J., dissenting).
The claim at issue in Senju was drawn to a method of
increasing corneal permeability to an ophthalmic antibiotic by
using disodium edetate (EDTA) at a very low concentration and at a
pH lower than that used in the cited prior art. EDTA is a
commonplace excipient in ophthalmic solutions, and at high
concentrations EDTA is known to increase corneal permeability to
help medicine in eye-drops reach the interior of the eye. At
the district court, the parties' experts disputed whether
several prior art references created an expectation of success or,
to